Tag: CBT > Medical Cannabis: Page 70

Legislation and Regulation

DEA Deschedules Epidiolex, Senators Urge SBA to Extend Economic Assistance to Cannabis Businesses: Week in Review

Effective immediately, the DEA has descheduled GW Pharmaceuticals’ Epidiolex, which was initially listed under Schedule V following its approval in 2018.

April 11, 2020

Interviews & Opinion

California’s Grim Outlook: Coronavirus Pandemic Expediting the State’s Existing Cannabis Market Failures

Now, more than two years into the state’s adult-use program, the struggle continues.

April 10, 2020

Interviews & Opinion

Federal Stay-at-Home Order? What Cannabis Businesses Need to Know

Industry advocates and attorneys weigh in on what federal COVID-19 guidance might entail and how it could impact businesses in the space.

April 8, 2020

Hemp Research

Charlotte Figi, Namesake of Charlotte’s Web CBD Cultivar and Subject of CNN ‘Weed’ Documentary, Dies Due to COVID-19 Symptoms

“Charlotte is no longer suffering,” photographer Nichole Montanez wrote on behalf of the Figi family. “She is seizure-free forever. Thank you so much for all of your love.”

April 8, 2020

Interviews & Opinion

How Curaleaf is Managing Its Multistate COVID-19 Response

VP of Retail Chris Melillo shares insight into the multistate operator’s state-by-state approach to each jurisdiction’s everchanging regulations, as well as lessons he’s learned from this unprecedented situation.

April 7, 2020

Finance

The DEA Has Descheduled Epidiolex. What Does That Mean?

This latest move may foreshadow a future of pharmaceutical drugs that contain CBD.

April 6, 2020

Legislation and Regulation

Ohio Medical Cannabis Dispensaries Permitted to Offer Curbside Pickup

The Ohio Board of Pharmacy is allowing retailers to conduct medical cannabis sales in their parking lots or on the sidewalks outside their stores during the COVID-19 crisis.

April 6, 2020

Legislation and Regulation

New York Strips Cannabis Legalization Proposal from State Budget, Mexico Senate Asks for Deadline Extension on Cannabis Legislation: Week in Review

New York Gov. Andrew Cuomo said there was “too little time” to fine-tune his plan to legalize adult-use cannabis ahead of the April 1 deadline to approve the state budget.

April 4, 2020

Interviews & Opinion

Passion for Medical Cannabis Fuels AAA Pharmaceutical Alternatives’ Transition to Maine’s Adult-Use Market: The Starting Line

Founder Aaron “Roy” Scalia is building on lessons learned as a caregiver in the state’s medical program to serve the broader adult-use market.

April 3, 2020

Legislation and Regulation

Minnesota Extends Medical Cannabis Enrollments for Patients to Limit Spread of COVID-19

Enrollments in the state’s medical cannabis program are extended until Aug. 1 or 60 days after the state’s peacetime emergency ends, whichever is later.

April 1, 2020

Interviews & Opinion

Americann CEO Discusses Cannabis Tech Center, COVID-19 Impact

Tim Keogh previews start-up of Massachusetts Cannabis Center and its progress amid the coronavirus pandemic.

March 31, 2020

Legislation and Regulation

NIDA Releases Request for Information on THC Dosing Standards

The National Institute of Drug Abuse has issued a request for comments on establishing and implementing a standard unit of dosage for THC in order to improve cannabis research efforts.

March 30, 2020